Crista Galli Ventures

Crista Galli Ventures operates as a specialized healthtech investment fund, strategically focusing on three distinct verticals within the healthcare innovation ecosystem. As the dedicated healthtech investment arm of IPQ Capital, the fund leverages the financial resources and strategic vision of the Pathiraja Fryland Møller family, whose roots extend across the United Kingdom and Denmark. This unique positioning allows the fund to combine the agility of a focused venture capital firm with the stability and long-term perspective characteristic of family office investments.

The fund's investment strategy centers on technological biology innovations, particularly those utilizing computational approaches to solve complex biological challenges. This vertical targets companies developing novel algorithms, machine learning applications, and data-driven methodologies that accelerate drug discovery, enhance molecular modeling, optimize protein engineering, or advance genomic analysis. By supporting computational biology startups, the fund aims to catalyze breakthroughs that fundamentally transform our understanding and treatment of diseases at the molecular level.

The second investment focus encompasses deeptech healthcare solutions that leverage cutting-edge technologies such as artificial intelligence, robotics, advanced materials, and quantum computing to address significant healthcare challenges. These investments typically involve companies developing sophisticated hardware-software combinations, novel diagnostic platforms, advanced medical devices, or breakthrough therapeutic delivery systems. The fund recognizes that these deeptech innovations often require longer development timelines but offer transformative potential to revolutionize healthcare delivery and patient outcomes.

Completing their investment thesis is a strategic focus on digital health ventures that enhance healthcare accessibility, efficiency, and personalization. This vertical includes telemedicine platforms, remote monitoring solutions, digital therapeutics, healthcare analytics, and patient engagement technologies that modernize healthcare delivery models. The fund's connection to the Pathiraja Fryland Møller family office provides portfolio companies with not only financial capital but also access to an extensive network of healthcare industry connections, scientific expertise, and operational guidance across European and global markets. This comprehensive support system positions startups for sustainable growth in the rapidly evolving healthtech landscape.